ColoradoIntroduced2026 Regular Session

HB26-1056 Prescription Drug Benefit Information Transparency

Latest: Jan 14, 2026 · House Committee on Health & Human Services Postpone Indefinitely

Health care

What it means

Our plain-English summary and constitutional analysis for this bill is not published yet. Every analysis is reviewed by an editor before it appears here.

How they voted

3 committee, procedural and amendment votes

House: Postpone House Bill 26-1056 indefinitely using a reversal of the previous roll call. There was no objection to the use of the reverse roll call, therefore, the bill was postponed indefinitely.

10 yes · 2 no · 1 other

Feb 17, 2026 · Result: pass

PartyYesNoOther / excused
Democratic7–1
Republican32–
How each member voted (13)

Party shown is each member's current party in our records. Official vote record

House: Refer House Bill 26-1056, as amended, to the Committee on Appropriations.

2 yes · 10 no · 1 other

Feb 17, 2026 · Result: fail

PartyYesNoOther / excused
Democratic–71
Republican23–
How each member voted (13)

Party shown is each member's current party in our records. Official vote record

House: Adopt amendment L.001 (Attachment I).

? yes · ? no

Feb 17, 2026 · Result: pass

Member-by-member votes are not loaded for this roll call yet. The tally above is from the official record.

Party shown is each member's current party in our records. Official vote record

Where it stands

  1. Jan 14, 2026 · House

    Introduced

    Introduced In House - Assigned to Health & Human Services

Full official history (2 actions)
  • Jan 14, 2026HouseIntroduced In House - Assigned to Health & Human Services
  • Feb 17, 2026HouseHouse Committee on Health & Human Services Postpone Indefinitely

Supporters and opponents

No documented positions yet. Every position we list links to its public source.

Official summary

Read the official summary (openstates)
The bill creates the "Prescription Drug Optimized Sourcing Transparency and Integrity Act" to prohibit a pharmacy benefit manager (PBM) or a health-care consultant from knowingly making or disseminating false or misleading statements or claims to a self-insured employer or policyholder about the legality or safety of a lawful prescription drug optimized sourcing program established by a pharmacy stewardship program.Upon written request by a self-insured employer, a PBM or health-care consultant is required to provide certain cost information for each prescription drug dispensed under the health benefit plan.The prohibition and information-sharing provisions of the bill do not restrict or limit the rights of a self-insured employer to purchase prescription drugs through and contract for a lawful prescription drug optimized sourcing program. The bill also recognizes that a pharmacy stewardship program is an effective cost-containment tool and is authorized when implemented in compliance with federal law and with the bill.(Note: This summary applies to this bill as introduced.)